NOS3 and congenital bilateral aplasia of vas deferens from CFTR mutation: Renin-angiotensin system inhibitors such as ACE inhibitors might also slow the progression of CAVD by increasing NO bioavailability via up-regulating eNOS expression, reducing bradykinin breakdown, and by supressing NOX-generated superoxide.290–294